HAMNO is widely used in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure allows it to act as a building block in the development of drugs targeting neurological disorders, including Alzheimer's disease and Parkinson's disease. Additionally, HAMNO is employed in the production of anti-inflammatory and analgesic medications, where it contributes to the enhancement of drug efficacy and stability. In research, it serves as a valuable tool for studying enzyme inhibition mechanisms, particularly in the context of neurodegenerative conditions. Its versatility also extends to the field of organic chemistry, where it is utilized in the synthesis of complex molecules for further experimental and therapeutic applications.